- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06871020
Periodontal Health and Patient Satisfaction of CAD/CAM Fiber-Reinforced vs. PFM Attachments in Distal Extension RPDs
July 5, 2026 updated by: Omnia M. Refai, Ain Shams University
Evaluation of Periodontal Health and Patient Satisfaction of CAD/CAM Fiber-Reinforced Composite Versus Porcelain Fused to Metal Extracoronal Attachment in Mandibular Distal Extension Removable Partial Dentures: A Randomized Clinical Trial
This randomized clinical trial aims to assess periodontal health and patient satisfaction in mandibular distal extension removable partial dentures using CAD/CAM fiber-reinforced composite versus porcelain-fused-to-metal extracoronal attachments.
Twelve participants with bilateral mandibular Kennedy Class I, retaining only the first premolars as the last standing abutments, will be randomly assigned to two groups.
Group I will receive OT extracoronal attachments made from CAD/CAM fiber-reinforced composite, while Group II will receive OT extracoronal attachments made from porcelain-fused-to-metal.
All participants will then receive a metallic removable partial denture.
The null hypothesis states that no significant differences will be observed in periodontal health and patient satisfaction between the two attachment types.
Study Overview
Status
Completed
Conditions
Detailed Description
Twelve participants with bilateral maxillary Kennedy Class I, with the first premolars as the last standing abutments, will be recruited based on strict inclusion criteria from the oral and maxillofacial prosthodontic outpatient clinic.
The canines and first premolars will be prepared to receive OT extracoronal attachments made from either CAD/CAM fiber-reinforced composite (Group I) or porcelain-fused-to-metal (Group II), according to group allocation.
All participants will then receive a metallic removable partial denture.
Periodontal health will be assessed through bleeding index, probing depth, and gingival recession at denture insertion and after six months and twelve months.
Patient satisfaction will also be evaluated at the twelve-month follow-up.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 12345
- Faculty Of Dentistry Ain Shams University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Mandibular partially edentulous bilateral distal extension Kennedy Class I with first premolars as last abutments.
- The opposing maxillary arch will be dentate.
- Angle class I maxillomandibular skeletal relation.
- The distal extension ridge will be well-formed and covered by healthy and firm mucosa.
- As verified by periapical radiographs, Abutments have healthy periodontal ligaments and an appropriate crown/root ratio (CRR).
- Crown/root ratio of the premolar abutment teeth is not less than 1:1. 5.
- The vertical distance between the ridge tissue and the opposing teeth of the study cases is not less than 7 mm. 6.
- The buccolingual dimension of the abutment teeth is not less than 6 mm.
Exclusion Criteria:
- Patients with any systemic disease that could affect the rate of bone resorption, which was confirmed by obtaining a through medical history.
- Patients with parafunctional habits (bruxism and clenching).
- Patients with any septic foci or impacted teeth as proved by panoramic radiograph, as well as patients with tilted or rotated abutments or soft tissue undercuts in areas that will be involved in the RDP design.
- Patients with any TMJ problems.
- Patients with any neuromuscular diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: OT Extracoronal attachment made from CAD-CAM fiber-reinforced composite resin.
The patient will receive a removable partial denture retained by bilateral OT extracoronal attachments made from CAD/CAM fiber-reinforced composite resin.
These attachments will be fabricated on the prepared first premolars and canines on each side.
|
Bilateral OT extracoronal attachments will be milled from fiber-reinforced composite resin after obtaining impressions of the prepared abutments.
This will be followed by an overall impression of fabricating a Co-Cr removable partial denture to be retained in the attachments.
|
|
Active Comparator: OT Extracoronal attachment made from porcelain-fused-to-metal
The patient will receive a removable partial denture retained by bilateral T Extracoronal attachment made from porcelain-fused-to-metal .
These attachments will be fabricated on the prepared first premolars and canines on each side.
|
Bilateral OT attachments manufactured from porcelain fused to metal by conventional technique after obtaining impressions of the prepared abutments.
This will be followed by an overall impression of fabricating a Co-Cr removable partial denture to be retained in the attachments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Bleeding index
Time Frame: At denture insertion ( baseline 0) and six months (180 days) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
The bleeding Index will be evaluated at denture insertion and after six months (180 days: Assessed using Mombelli's Bleeding Index, which scores bleeding on probing (BOP) from 0 (no bleeding) to 3 (heavy bleeding).
|
At denture insertion ( baseline 0) and six months (180 days) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
|
Evaluation of Probing Pocket Depth (PPD)
Time Frame: At denture insertion ( baseline 0), six months (T1) , and 12 months (T2) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
Evaluation of Probing Pocket Depth (PPD)will be evaluated at denture insertion and after six months: Measured on buccal and lingual aspects of the four abutments following the American Academy of Periodontology protocol.
Six readings per abutment will be averaged.
|
At denture insertion ( baseline 0), six months (T1) , and 12 months (T2) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
|
Evaluation Gingival Index (GI)
Time Frame: At denture insertion ( baseline 0), six months (T1) , and 12 months (T2) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
Evaluation of Gingival index: Evaluated using Löe and Silness (1963), scoring gingival inflammation from 0 (healthy) to 3 (severe inflammation with spontaneous bleeding).
|
At denture insertion ( baseline 0), six months (T1) , and 12 months (T2) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Patient Satisfaction
Time Frame: After tweleve months (180 days) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
Patient satisfaction will be evaluated using the McGill Denture Satisfaction Questionnaire and a visual analog scale (VAS).
Satisfaction will be measured across multiple aspects, including ease of cleaning, speech ability, comfort, esthetics, stability, mastication of various foods, masticatory efficiency, oral condition, and overall satisfaction.
Patients will rate each item on a 0-100 scale, where 0 represents complete dissatisfaction and 100 indicates total satisfaction.
|
After tweleve months (180 days) after delivery of mandibular removable partial denture retained on double OT Extracoronal attachments
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Omnia M. Refai, PHD, Ain Shams Univeristy
- Study Director: Noha Helmy Hassan Nawar, PHD, Ain Shams Univeristy
- Principal Investigator: Heba A. Salama, PHD, Misr International University
- Principal Investigator: Abdel Rahman Maged, PHD, Misr International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2025
Primary Completion (Actual)
January 1, 2026
Study Completion (Actual)
March 15, 2026
Study Registration Dates
First Submitted
February 22, 2025
First Submitted That Met QC Criteria
March 5, 2025
First Posted (Actual)
March 11, 2025
Study Record Updates
Last Update Posted (Actual)
July 8, 2026
Last Update Submitted That Met QC Criteria
July 5, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FDASU-RecIR122439
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.